Big Pharma eyes up Pharmac in trade talks

By Ruth Laugesen In Commentary

Print Share
11th June, 2011
Pharmac used to be as popular as vermin. Think back to Herceptin and the cancer-stricken women who protested against Pharmac for denying them subsidised year-long courses of the drug and perhaps another chance at life. Back then, Pharmac was treating New Zealand women like “lab rats”, according to the Breast Cancer Aotearoa Coalition. It was offering treatment that was “unproven, unsafe and cheap”, said National MP Dr Jackie Blue, a specialist in the area of breast cancer, by funding a nine-week but not a 12-month course of Herceptin. It was subjecting New Zealand women to what might ...

Get full access to Listener.co.nz

Subscribers can read the full version of this story.

You can subscribe and get full online access for as little as $5 per week.

Enjoy the high-quality, in-depth journalism of the Listener magazine with convenient online access. This includes access to thousands of archived articles and up-to-date TV and entertainment listings.

Our great content is available online even before it hits the shelves, and includes more focus on breaking news. With our responsive design you get a great reader experience whether you read from your home computer, tablet, or even smartphone.

Already a subscriber? Just to read full version of this story.

Already an existing print subscriber? As part of your magazine subscription you are entitled to receive full access to the New Zealand Listener Online content. Click here for instructions on how to redeem your digital access.

Or you can subscribe now to get unlimited access to listener.co.nz.

More by Ruth Laugesen

Switch to our mobile site